China conditionally approves four selfdeveloped COVID vaccines official
2021-02-26 20:09
A staff member checks the packages of the COVID inactivated vaccine at Sinovac Biotech Ltd, in Beijing, Dec , . PhotoXinhua    BEIJING  China has granted conditional market approval to four selfdeveloped COVID vaccines, Minister of Science and Technology Wang Zhigang said Friday. China has adopted five technological approaches in developing COVID vaccines. China now has  selfdeveloped COVID vaccines undergoing clinical trials, with seven undergoing phase clinical trials, Wang told a press conference held in Beijing. China has also included  drugs and treatment methods in its diagnosis and treatment plan for COVID, Wang added.